Clinwire sample data
Clinwire helps sites and site networks get in front of trials before they hit public registries. Below is a snapshot pulled in August 2026: emerging and mid-size sponsors who've shown signs of upcoming studies over the past year, and every trial behind them.
Start with the sponsor listA pattern worth knowing going in: small sponsors skew early-phase, large sponsors skew Phase 3. If your site is built for first-in-human work, that's concentrated in sponsors under 50 employees. If you're staffing for Phase 3 enrollment, look to the larger sponsors, there are fewer of them, but that's where the volume is.
Section one
100 emerging and mid-size sponsors at 5,000 employees or fewer, drawn from companies that showed signs of upcoming studies over the past year. We skipped the household large pharma names in favor of sponsors who still have room for a new site relationship. Country reflects the sponsor's head office, not where a study will run.
Showing 100 of 100 sponsors
Section two, across the full Clinwire dataset
Zoom out from the 100 sponsors above and this is the full picture: every upcoming trial Clinwire tracked over the past year, cut by phase and by therapeutic area.
Showing 2,321 of 2,408 upcoming trials
Sorted by total. Select an area to filter the indications beside it.
The 15 largest indications across all areas.
The anchor for everything above and below. Select a segment to add or remove that phase.
Undeclared means the sponsor has not stated a phase yet, not that the field is empty. It starts unselected here, so the default view shows trials with a known phase. Add it back in to see all 2,408.
A forward looking pipeline view, not a calendar history.
Based on 1,188 studies with an announced start window of 2026 or later. A further 1,066 studies have been identified but have not yet communicated a start date, and 154 were announced with windows that have since elapsed.
Head office headcount, banded. Hover a column for the phase split.
The two smallest bands carry 1,430 of the 2,408 upcoming trials, with 460 Phase 1 studies in the 1 to 50 employee range. Sponsors above 5,000 employees run the opposite shape, with 96 of their 182 upcoming studies at Phase 3.
This page stopped moving in August 2026
What you're looking at is a snapshot. Clinwire itself doesn't stop, it's a live system that keeps watching for sponsor activity like this year-round, updating as sponsors announce rather than once a year. See it running on your own therapeutic areas.
See it live